Autolus Therapeutics PLC (NASDAQ:AUTL)
| 2.32 Delayed Data As of Sep 27 |  -0.02 / -0.85%Today’s Change | 1.60 Today|||52-Week Range 3.54 | +22.11% Year-to-Date |
Institutional investors purchased a net $30.3 million shares of AUTL during the quarter ended March 2019. This may signal that the smart money is gaining interest in this company as the 64.40% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
| Other institutional | 62.46% |
| Mutual fund holders | 1.94% |
| Individual stakeholders | -- |
Largest Quarterly Institutional
Transactions
Latest Institutional Activity
| 6/30/2023 | PARADIGM BIOCAPITAL ADVISORS LP Bought 9.2 Million shares of Autolus Therapeutics PLC |
| 6/30/2023 | TFG ASSET MANAGEMENT UK LLP Bought 2.0 Million shares of Autolus Therapeutics PLC |
| 6/30/2023 | AFFINITY ASSET ADVISORS LLC Bought 1.6 Million shares of Autolus Therapeutics PLC |
Top 10 Owners of Autolus Therapeutics PLC
| Stockholder | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| Syncona Investment Management Ltd... | 12.33% | 21,346,829 | 68,523,321 | 0 | 0.00% |
| Deep Track Capital LP | 8.67% | 15,000,000 | 48,150,000 | 0 | 0.00% |
| Qatar Investment Authority (Inves... | 8.67% | 15,000,000 | 48,150,000 | +15,000,000 | -- |
| TFG Asset Management UK LLP | 6.93% | 12,000,000 | 38,520,000 | +2,000,000 | +20.00% |
| Tetragon Financial Management LP | 5.47% | 9,461,883 | 30,372,644 | +9,461,883 | -- |
| Paradigm BioCapital Advisors LP | 5.33% | 9,217,150 | 29,587,052 | +9,217,150 | -- |
| Armistice Capital LLC | 4.20% | 7,264,000 | 23,317,440 | -2,408,000 | -24.90% |
| Nantahala Capital Management LLC | 2.47% | 4,272,203 | 13,713,772 | -3,419,610 | -44.46% |
| Odey Asset Management LLP | 1.83% | 3,158,395 | 10,138,448 | +658,995 | +26.37% |
| J.O. Hambro Capital Management Lt... | 1.15% | 1,996,355 | 6,408,300 | +138,264 | +7.44% |
Top 10 Mutual Funds Holding Autolus Therapeutics PLC
| Mutual fund | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| iShares Biotechnology ETF | 0.49% | 844,066 | 2,709,452 | +4,326 | +0.52% |
| Crown Sigma UCITS Plc - LGT Crown... | 0.32% | 550,000 | 1,765,500 | +550,000 | -- |
| Regnan UFI - Regnan Global Equity... | 0.30% | 511,929 | 1,643,292 | +96,957 | +23.36% |
| Ashburton Investments SICAV - Glo... | 0.28% | 490,474 | 1,574,422 | 0 | 0.00% |
| Harbor Disruptive Innovation Fund | 0.13% | 216,283 | 694,268 | +27,708 | +14.69% |
| Erste Stock Biotec | 0.11% | 195,000 | 625,950 | 0 | 0.00% |
| ALPS Medical Breakthroughs ETF | 0.08% | 130,809 | 419,897 | 0 | 0.00% |
| Harbor Disruptive Innovation ETF | 0.05% | 85,559 | 274,644 | 0 | 0.00% |
| Fidelity Nasdaq Composite Index F... | 0.05% | 78,373 | 251,577 | +3,868 | +5.19% |
| JOHCM Regnan Global Equity Impact... | 0.04% | 75,233 | 241,498 | 0 | 0.00% |